ARKG vs RSP
ARK Genomic Revolution ETF vs Invesco S&P 500 Equal Weight ETF
ARKG$43.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
RSP$214.01
Invesco S&P 500 Equal Weight ETF
S&P 500 with each stock equally weighted.
Expense: 0.20%Yield: 1.51%
Quick take
- • RSP has the lower expense ratio at 0.20% vs 0.75% for ARKG.
- • RSP pays a higher dividend yield (1.51%).
Side-by-side metrics
| Metric | ARKG | RSP |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.20% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.51% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $93.66B |
YTD return | 44.53% | 11.67% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.85 |
P/E ratio | — | 22.17 |
Last price | $43.17 | $214.01 |
Inception | — | — |
Issuer | ARK | Invesco |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector breakdown · ARKG
Healthcare100.0%
RSP top holdings
Top holdings · RSP
| MRNA | Moderna Inc | 0.29% |
| GLW | Corning Inc | 0.29% |
| AMAT | Applied Materials Inc | 0.28% |
| KLAC | KLA Corp | 0.27% |
| TER | Teradyne Inc | 0.27% |
| SNDK | SanDisk Corp Ordinary Shares | 0.27% |
| GEV | GE Vernova Inc | 0.26% |
| LRCX | Lam Research Corp | 0.26% |
| TECH | Bio-Techne Corp | 0.26% |
| UAL | United Airlines Holdings Inc | 0.26% |
Sector breakdown · RSP
Real Estate5.9%
Consumer Cyclical10.9%
Basic Materials3.9%
Consumer Defensive6.3%
Technology17.3%
Communication Services4.0%
Financial Services13.9%
Utilities6.3%
Industrials15.7%
Energy3.8%
Healthcare12.0%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About RSP
RSP (Invesco S&P 500 Equal Weight ETF) is S&P 500 with each stock equally weighted. Managed by Invesco, the fund carries $93.7B in assets under management, an expense ratio of 0.20%, a dividend yield of 1.51%. Its largest holding is Moderna Inc (MRNA), which represents 0.3% of the portfolio. Real Estate is the fund's largest sector exposure at 5.9%.